Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | NBTX | XERS | ||
| Company | Immune Design CS | Nanobiotix S.A. ADR | Xeris Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 6.59 | 1.9100 | ||
| High | 5.85 | 6.59 | 1.9300 | ||
| Low | 5.84 | 6.58 | 1.8400 | ||
| Last | 5.85 | 6.58 | 1.8600 | ||
| Change | unch | +0.26 | -0.0350 | ||
| % Change | unch | +4.11% | -1.85% | ||
| Volume | 103,800 | 3,057 | 212,667 | ||
| 20-Day Average Volume | 409,005 | 56,710 | 1,272,794 | ||
| Previous Close | 5.85 | 6.32 | 1.8950 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 5.90 | 1.8182 | ||
| 20-Day Raw Stochastic | 100.00% | 100.00% | 45.07% | ||
| 20-Day Relative Strength | 88.63% | 58.86% | 41.64% | ||
| Weighted Alpha | -20.50 | +3.37 | -29.76 | ||
| Today's Opinion | 88% Buy | 32% Sell | 72% Sell | ||
| Previous Opinion | 88% Buy | 72% Sell | 56% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | +16.10% since 04/30/24 | +5.71% since 04/30/24 | ||
| Low | 5.84 on 04/01/19 | 5.85 on 05/01/24 | 1.7300 on 05/01/24 | ||
| High | 5.85 on 04/01/19 | 6.78 on 05/07/24 | 1.9700 on 05/06/24 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | +2.88% since 04/05/24 | -9.31% since 04/05/24 | ||
| Low | 5.82 on 03/14/19 | 5.13 on 04/17/24 | 1.6900 on 04/26/24 | ||
| High | 5.85 on 04/01/19 | 6.78 on 05/07/24 | 2.0650 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -5.44% since 02/07/24 | -29.66% since 02/07/24 | ||
| Low | 1.22 on 01/03/19 | 5.13 on 04/17/24 | 1.6900 on 04/26/24 | ||
| High | 5.85 on 04/01/19 | 7.65 on 02/08/24 | 3.2600 on 02/15/24 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | +19.58% since 11/07/23 | -1.33% since 11/07/23 | ||
| Low | 1.10 on 12/24/18 | 5.13 on 04/17/24 | 1.4600 on 11/15/23 | ||
| High | 5.85 on 04/01/19 | 8.96 on 01/18/24 | 3.2600 on 02/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 297,881 | 280,941 | ||
| Shares Outstanding, K | 48,365 | 47,133 | 148,254 | ||
| Annual Sales | 2,200,000 | 39,190,000 | 163,910,000 | ||
| Annual Net Income | -54,760,000 | -42,970,000 | -62,260,000 | ||
| Last Quarter Sales | 480,000 | N/A | 44,390,000 | ||
| Last Quarter Net Income | -13,600,000 | N/A | -13,390,000 | ||
| 60-Month Beta | 3.48 | 0.26 | 2.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.10 on 03/06/24 | ||
| Latest Earnings Date | 05/01/19 | 04/22/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||